Abstract
Background. Malignant effusion in invasive breast cancer, either pleural or pericardial, is associated with a poor survival rate. We investigated the role of the location of invasive breast cancer in developing malignant pleural or pericardial effusion.
Methods. Three thousand eight hundred and fifty six women with a history of invasive breast cancer between 1960 and 1994 were analyzed in a retrospective study. Two hundred and six patients (5.34%; group A) developed malignant pleural and/or pericardial fluid as the first visible clinical sign of distant metastasis. A control group of 206 patients (group B) without malignant effusions were matched in terms of clinical and pathological characteristics. The two groups were compared in respect of the location of the primary tumor. Fifty patients in group A (n = 50; 24.2%) had tumors in the inner quadrants, 83 patients (n = 83; 40.3%) in the outer quadrants, and 13 patients (n = 13; 6.3%) in a central location. No data were available for 60 patients (n = 60; 29.1%). In group B, 12 patients (n = 12; 5.9%) had tumors in the inner quadrants, 140 patients (n = 140; 68.0%) in the outer quadrants, 14 patients (n = 14; 6.8%) had centrally located tumors, while no data were available for 40 patients (n = 40; 19.4%). Invasive ductal carcinomas (IDC) located in the inner quadrants were highly significantly associated with increased pleural or pericardial effusion as the first site of distant metastasis (p ≤ 0.0001; chi-square tests).
Conclusion. IDC in the inner quadrants were associated with a 4-fold higher rate of malignant pleural or pericardial effusions. Further studies will have to determine whether tumor location is a criterion for more aggressive adjuvant therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Banerjee AK, Willetts I, Robertson JFR, Blamey RW: Pleural effusion in breast cancer: a review of the Nottingham experience. Eur J Surg Oncol 20: 33–36, 1994
Fentiman IS, Millis R, Sexton S, Hayward JL: Pleural effusion in breast cancer; a review of 105 cases. Cancer 47: 2087–2092, 1981
Goldsmith HS, Bailey HD, Callahan EL, Beattie EJ: Pulmonary lymphangitic metastases from breast carcinoma. Arch Surg 94: 483–488, 1967
Raju RN, Kardinal CG: Pleural effusion in breast carcinoma. Analysis of 122 cases. Cancer 48: 2524–2527, 1981
Rosen PP: Rosens' Breast Pathology. Lippincott-Raven Publishers, Philadelphia, 1997, p 3
Tavassoli FA: Pathology of the Breast. Appleton & Lange, Norwalk, 1992, pp 35–36
Bobin JY, Zinzindohoue C, Isaac S, Saadat M, Roy P: Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. Eur J Cancer 35(4): 569–573, 1999
Johnson N, Soot L, Nelson J, Franzini MD, Vea H, Gruner S, Kulawiak L, Young K: Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. J Surg Oncol 179(5): 386–388, 2000
Noguchi M, Tsugawa K, Miwa K: Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 73(2): 75–80, 2000
Dieterich M, Goodman S, Rojas-Corona R, Emralino A, Jimenez-Joseph D, Sherman M: Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. Acta Cytol 38: 945–952, 1994
Shapiro CL: Malignant effusions in breast cancer. In: Harris JR, Hellman S, Henderson I, Kinne DW (eds) Breast Diseases. 2 edn, Lippincott, Philadelphia, 1991, pp 735–747
Van de Moolengraft FJ, Voojs GP: The interval the diagnosis of malignancy and the development of effusions, with reference to the role of cytological diagnosis. Acta Cytol 32: 183–187, 1988
Gaffney DK, Tsodikov A, Wiggins CL: Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21(3): 467–472, 2003
Zucali R, Mariani L, Marubini E, Kenda R, Lozza L, Rilke F, Veronesi U: Early breast cancer: evaluation of the site of the primary tumor. J Clin Oncol 16(4): 1363–1366, 1998
Swanepol E, Apffelstaedt JP: Malignant pericardial effusions in breast cancer: terminal event or treatable complication. J Surg Oncol 64(4): 308–311, 1997
Harris JR, Lippman ME, Morrow M, Osborne CK: Diseases of the Breast. 2 edn, Lippincott, Philadelphia, 2000, pp 893–899
Kamakura T, Akazawa K, Nomura Y, Sugimachi K, Nose Y: Poor prognosis of lower quadrant breast carcinoma. Nishi Nippon Study Group on adjuvant chemo-endocrine therapy for breast cancer. J Surg Oncol 61(4): 295–299, 1996
Lohrisch C, Jackson J, Jones A, Mates D, Olivotto IA: Relationship between tumor location and relapse in 6,781 woman with early invasive breast cancer. J Clin Oncol 18(15): 2828–2835, 2000
Kroman N, Wohlfahrt J, Mouridson HT, Melbey M: Influence of tumor location on breast cancer prognosis. Int J Cancer 105(4): 542–545, 2003
Haigh PI, Hansen NM, Qi K, Giuliano AE: Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7(1): 21–27, 2000
Hammer J, Track C, Seewald DH: Breast cancer: the medial tumor location-an unfavourable disease! Results from 644 patients (1984-1995). Radiother Oncol 58: 38, 2001
Freedman GM, Fowble BL, Nicolaou N et al.: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 46: 805–814, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pokieser, W., Cassik, P., Fischer, G. et al. Malignant Pleural and Pericardial Effusion in Invasive Breast Cancer: Impact of the Site of the Primary Tumor. Breast Cancer Res Treat 83, 139–142 (2004). https://doi.org/10.1023/B:BREA.0000010706.24181.b6
Issue Date:
DOI: https://doi.org/10.1023/B:BREA.0000010706.24181.b6